Literature DB >> 33320558

Tissue Engineering Measurands.

Deepika Arora1, Greta Babakhanova1, Carl G Simon1.   

Abstract

A metrological perspective for thinking about the characterization of tissue engineered medical products (TEMPs) may help improve communication between researchers. During the development lifecycle of a TEMP, many product properties are measured over the long path to a product release. The selection of each measurement is designed to establish that the product is safe and efficacious (i.e., successful). However, there is often miscommunication during discussions of product characterization. The miscommunication stems from inherent assumptions that are made about the measurements. A "measurand chart" can help clarify these assumptions to enable a more coherent discussion of the value of each measurement. A measurand is defined as "the quantity or property intended to be measured". Tissue engineering measurands are discussed in terms of three case studies including "cell viability in a scaffold", "potency", and "biocompatibility". Topics including a measurement model, defining tissue engineering measurands and definitional uncertainty, are discussed to further refine thinking about tissue engineering measurands. Awareness of these concepts while discussing product characterization can enhance communication and strategic thinking so that the resulting plan is clear and purposeful.

Keywords:  biocompatibility; cell viability; measurand; measurement; metrology; potency; scaffold; standards; tissue engineering

Mesh:

Year:  2020        PMID: 33320558     DOI: 10.1021/acsbiomaterials.0c00475

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  1 in total

1.  Quantitative, traceable determination of cell viability using absorbance microscopy.

Authors:  Greta Babakhanova; Stephen M Zimmerman; Laura T Pierce; Sumona Sarkar; Nicholas J Schaub; Carl G Simon
Journal:  PLoS One       Date:  2022-01-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.